Cargando…

Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis

Common nucleotide-binding oligomerization domain containing 2 (NOD2) gene variants have been associated with bacterial infections (BIs) in cirrhosis, in particular, spontaneous bacterial peritonitis, and mortality. Our aim was to evaluate the independent association of NOD2 variants with BI accordin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reichert, Matthias Christian, Ripoll, Cristina, Casper, Markus, Greinert, Robin, Vandieken, Edith, Grünhage, Frank, Appenrodt, Beate, Zipprich, Alexander, Lammert, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369875/ https://www.ncbi.nlm.nih.gov/pubmed/30702490 http://dx.doi.org/10.14309/ctg.0000000000000002

Ejemplares similares

The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial
por: Casper, Markus, et al.
Publicado: (2015)

Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant
por: Merkel, Melissa, et al.
Publicado: (2021)

Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
por: Rauber, Philip, et al.
Publicado: (2018)

Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascites
por: Ripoll, Cristina, et al.
Publicado: (2022)

Common variation in FAM155A is associated with diverticulitis but not diverticulosis
por: Reichert, Matthias C., et al.
Publicado: (2020)

Serum 25-hydroxyvitamin D levels and mortality risk in patients with liver cirrhosis: a protocol for a systematic review and meta-analysis of observational studies
por: Völker, Désirée, et al.
Publicado: (2019)

Identification of Combined Genetic Determinants of Liver Stiffness within the SREBP1c-PNPLA3 Pathway
por: Krawczyk, Marcin, et al.
Publicado: (2013)

Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice
por: Weber, Susanne N., et al.
Publicado: (2021)

Hepatic Arterial Vasodilation Is Independent of Portal Hypertension in Early Stages of Cirrhosis
por: Moeller, Miriam, et al.
Publicado: (2015)

The PNPLA3 rs738409 148M/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C Cirrhosis
por: Nischalke, Hans Dieter, et al.
Publicado: (2011)

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter
por: Arslanow, Anita, et al.
Publicado: (2016)

Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
por: Hollenbach, Marcus, et al.
Publicado: (2017)

Increased Circulating VAP-1 Levels Are Associated with Liver Fibrosis in Chronic Hepatitis C Infection
por: Kraemer, Marcel, et al.
Publicado: (2019)

A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population
por: Müllenbach, Roman, et al.
Publicado: (2012)

Volume–Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE—A Feasibility Study
por: Reichert, Matthias Christian, et al.
Publicado: (2020)

Effects of common haplotypes of the ileal sodium dependent bile acid transporter gene on the development of sporadic and familial colorectal cancer: A case control study
por: Grünhage, Frank, et al.
Publicado: (2008)

Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis
por: Marasco, Giovanni, et al.
Publicado: (2022)

Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
por: Krawczyk, Marcin, et al.
Publicado: (2017)

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease
por: Krawczyk, Marcin, et al.
Publicado: (2017)

Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma
por: Michel, Maurice, et al.
Publicado: (2019)

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients
por: Jüngst, Christoph, et al.
Publicado: (2017)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2016)

Liver stiffness and thrombin generation in compensated cirrhosis
por: Dillon, Audrey, et al.
Publicado: (2019)

Small Bowel Abnormalities in Patients with Compensated Liver Cirrhosis
por: Aoyama, Taiki, et al.
Publicado: (2012)

Correction: Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2018)

Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis
por: Bloom, P.P., et al.
Publicado: (2022)

Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
por: Bazwinsky-Wutschke, Ivonne, et al.
Publicado: (2019)

Nod2 Mediates Susceptibility to Yersinia pseudotuberculosis in Mice
por: Meinzer, Ulrich, et al.
Publicado: (2008)

Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients
por: Lakatos, Peter Laszlo, et al.
Publicado: (2007)

Frequency of minimal hepatic encepalopathy in illeterate patients with compensated cirrhosis
por: Zuberi, Bader Faiyaz, et al.
Publicado: (2016)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Compensated liver cirrhosis: Natural course and disease-modifying strategies
por: Kumar, Ramesh, et al.
Publicado: (2023)

Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis—a randomized controlled trial
por: Ripoll, Cristina, et al.
Publicado: (2023)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 1: compensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

The Molecular Basis of NOD2 Susceptibility Mutations in Crohn's Disease
por: Strober, Warren, et al.
Publicado: (2008)

The NOD2 Single Nucleotide Polymorphisms rs2066843 and rs2076756 Are Novel and Common Crohn's Disease Susceptibility Gene Variants
por: Glas, Jürgen, et al.
Publicado: (2010)

Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis
por: Muharram, Ghaffar, et al.
Publicado: (2023)

Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
por: Buscail, Camille, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gcnmqsu99vmhpi61dgrnvlm2mt